:: EFGCP ONLINE ::

EFGCP Children's Medicines Working Party Annual 6th Conference & DIA 4th Paediatric Forum on

Current & Future Perspectives for Paediatric Medicines: Visions, Daily Challenges, Ways Forward

The EFGCP Children’s Medicines Working Party and DIA Europe are pleased to announce their second joint paediatric conference. Traditional paediatric meetings of both societies in the past and the joint meeting in 2009 have attracted top level speakers from the European Medicines Agency (EMA), FDA, national authorities, WHO, academia, pharmaceutical industry and parents & patients’ organizations. This second joint program will again offer the opportunity for intensive discussion among stakeholders in different topics relevant for pediatric medicines. We will address visions, daily challenges and ways forward in paediatric drug development. On this basis, the conference will also offer excellent networking opportunities for all attendees. The conference will include three parallel breakout sessions on each day for a lively interactive discussion. Furthermore, it will provide participants with the opportunity of asking questions by e-mail before the conference and during the morning of day 1, which will be in the afternoon addressed by a speaker panel chaired by Paolo Tomasi, European Medicines Agency (EMA).

New! Ask your burning questions in advance to the programme committee!

Dear Conference Participants,

We would like to launch a new initiative to offer as much interactivity as possible and exchange feedback into the key issues to be discussed at this conference. You are invited to send any burning question you have in relation to paediatric drug development to a dedicated e-mail address. We would recommend that you address questions on a general level, i.e. not addressing specific projects. Your name will be treated in full confidentiality, only the content of the question will be discussed at the conference. Thank you in advance for your input!

The Programme Committee

How to proceed? Send your question by 21 September 2010 to paediatrics@efgcp.eu, a moderator appointed by the Programme Committee will process this futher and live tentative answers will be provided and discussed on 28 September in Plenary Session 2.